Molecular Formula | C19H17NO3 |
Molar Mass | 307.34 |
Density | 1.271±0.06 g/cm3(Predicted) |
Boling Point | 554.1±29.0 °C(Predicted) |
Solubility | 10 mM in DMSO |
Appearance | Red-violet solid |
Color | , light pink to red to very dark purple |
pKa | 14.31±0.20(Predicted) |
Storage Condition | 2-8°C |
In vitro study | SF1670 showed potent cytotoxicity in HBEC,PC-3,H1299 cells, with IC50 of 5 μm, 10 μm, 44 μm, respectively. SF1670 stimulates the process of angiogenesis in a mouse aortic ring artificial basement membrane angiogenesis model. SF1670 increases chemoattractant-induced PtdIns(3,4,5)P3 signaling in neutrophils and enhances neutrophil function. |
In vivo study | In neutropenic peritonitis and bacterial Pneumonia mice, SF1670 pretreatment (500 nM, I. V.) increased Bactericidal Capacity and decreased Pneumonia of Mortality Rate associated with neutropenia. |
Hazard Symbols | Xi - Irritant |
Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | 26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. |
WGK Germany | 3 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.254 ml | 16.268 ml | 32.537 ml |
5 mM | 0.651 ml | 3.254 ml | 6.507 ml |
10 mM | 0.325 ml | 1.627 ml | 3.254 ml |
5 mM | 0.065 ml | 0.325 ml | 0.651 ml |